The manager will develop and execute scalable onboarding and marketing programs to support the successful launch and growth of Caris Detect partners. They will collaborate across internal teams to create educational resources and communication strategies that enhance partner engagement and commercial performance.
The Regional Business Director will lead and develop a team of Account Executives to drive market adoption and utilization of the MI Clarity prognostic assay. This role involves executing commercial strategies, building executive-level relationships, and collaborating cross-functionally to ensure clinical success and revenue growth.
The Director of Scientific Engagement develops and executes scientific content strategies to support the launch and commercialization of precision oncology products. This role acts as the medical marketing lead on cross-functional teams, translating complex clinical data into compelling communications for various stakeholders.
The Oncology Account Executive is responsible for driving territory growth through strategic prospecting, consultative selling, and the acquisition of new accounts. They build and maintain strong clinical relationships with oncologists and healthcare stakeholders to ensure the successful adoption of molecular profiling solutions.
The Oncology Account Executive is responsible for driving territory growth through new account acquisition and the expansion of existing customer relationships. They will provide clinical education, manage the customer experience, and collaborate with internal teams to position molecular profiling solutions.
The Oncology Account Executive is responsible for driving territory growth through strategic prospecting, consultative selling, and the acquisition of new accounts. They manage clinical and operational relationships with oncologists and pathologists to ensure the successful adoption of molecular profiling solutions.
The Oncology Account Executive is responsible for driving territory growth through strategic prospecting, consultative selling, and the acquisition of new accounts. They manage clinical and operational relationships with oncologists and pathologists while ensuring an exceptional customer experience throughout the molecular profiling order lifecycle.
The Vice President of Strategic Accounts manages executive-level partnerships to drive the adoption of precision medicine solutions across health systems. This role coordinates cross-functional teams and provides strategic leadership to ensure the successful implementation and growth of oncology programs.
The Embedded Caris Operations Manager manages end-to-end operational workflows and case execution to support precision medicine programs. They serve as a primary partner to providers and pathology teams to ensure high-quality case management and workflow efficiency.
The Embedded Caris Operations Manager manages end-to-end operational workflows and case execution to support precision medicine programs. This role acts as a primary partner to providers and pathology teams to ensure high-quality patient experiences and efficient report delivery.
The Regional Business Director leads, coaches, and develops a sales team to execute growth strategies and meet revenue targets within the oncology and diagnostic market. This role involves building senior-level relationships, analyzing market opportunities, and ensuring the effective delivery of precision medicine solutions.
The Molecular Geneticist is responsible for developing and utilizing molecular biology techniques to identify tumor alterations and inherited conditions. They will oversee laboratory assays, interpret complex genomic data, and provide clinical guidance to oncology professionals.
The Data Integration Engineer will install automated data integrations between customer systems and Caris environments to ingest healthcare data. They will also manage ETL processes and lead data discovery projects to support internal analytic dashboards.
The Molecular Science Liaison communicates the value of Caris Molecular Intelligence to physicians and key opinion leaders through face-to-face discussions and clinical presentations. They also act as a conduit for information between the medical community and the company while maintaining up-to-date knowledge of oncology research.
The Pathology Solutions Consultant serves as a subject matter expert to optimize laboratory workflows, specimen management, and operational performance for molecular testing. They partner with pathology laboratories to conduct assessments, implement best practices, and drive continuous improvement initiatives to enhance testing success and efficiency.
The Pathology Solutions Consultant acts as a primary operational advisor to pathology laboratories, focusing on optimizing specimen management and laboratory workflows for precision medicine. They lead onsite assessments, develop data-driven improvement strategies, and collaborate with cross-functional teams to enhance testing success and operational efficiency.
The Pathology Solutions Consultant acts as a primary operational advisor to pathology laboratories, optimizing specimen management and laboratory workflows to improve testing success. They collaborate with cross-functional teams to implement best practices, analyze performance data, and deliver tailored operational solutions for precision medicine initiatives.
The Pathology Solutions Consultant serves as a primary operational consultant to optimize laboratory workflows, specimen management, and performance for molecular testing. They collaborate with cross-functional teams and pathology leadership to implement best practices and data-driven improvements.
The National Account Molecular Science Liaison serves as a scientific expert responsible for developing and executing strategic scientific engagement across large oncology networks and integrated delivery networks. This role involves collaborating with executive clinical leadership to advance precision oncology initiatives and support the implementation of molecular profiling programs.
The Molecular Science Liaison communicates the value of Caris Molecular Intelligence to physicians and key opinion leaders through clinical presentations and educational engagement. They act as a vital link between the medical community and the company to provide feedback on research, clinical trials, and therapeutic approaches.
The Oncology Case Manager is responsible for managing and growing business relationships with existing customers within an assigned territory. They ensure a high-quality experience from order initiation through the delivery of laboratory reports while supporting physicians with the CMI platform.
The Oncology Account Executive is responsible for driving territory growth through new account acquisition and the expansion of existing customer relationships. They will provide clinical and technical expertise to oncologists and pathologists while managing the full customer lifecycle for molecular profiling solutions.
Drive territory growth through new account acquisition and the expansion of existing customer relationships for tumor profiling solutions. Build strong clinical relationships with oncologists and pathologists while ensuring a seamless customer experience from order to report delivery.
Design, implement, and operate secure, scalable Linux-based infrastructure with a primary focus on production Kubernetes/AWS EKS workloads. Lead cluster automation, reliability, and compliance initiatives while managing CI/CD pipelines and infrastructure as code.
Drive territory growth through new account acquisition and the expansion of existing customer relationships within oncology. Position Caris as the preferred partner for tumor profiling solutions while managing the full customer experience from order to delivery.
Lead the oncology sales function in the West region to meet and exceed volume and revenue targets. Develop and execute sales strategies while managing a team of Regional Business Directors and Molecular Oncology Specialists.
Drive territory growth through new account acquisition and the expansion of existing customer relationships within the oncology sector. Position Caris as the preferred partner for tumor profiling solutions by building strong clinical relationships with oncologists and pathologists.
Drive territory growth through new account acquisition and the expansion of existing customer relationships within the oncology sector. Position Caris as the preferred provider of tumor profiling solutions by building strong clinical and operational relationships with healthcare stakeholders.
Manage the product roadmap for liquid oncology offerings from concept to commercial adoption within an assigned geography. Collaborate with commercial teams to execute go-to-market strategies and provide consultative business solutions to hospital systems and laboratory professionals.
Drive territory growth through new account acquisition and the expansion of existing customer relationships within oncology. Position Caris as the preferred partner for tumor profiling solutions while managing the full customer experience from order to report delivery.
Drive territory growth through new account acquisition and the expansion of existing customer relationships within oncology. Position Caris as the preferred partner for tumor profiling solutions while managing the full customer experience from order to report delivery.
Drive territory growth through new account acquisition and the expansion of existing customer relationships within the oncology sector. Position Caris as the preferred provider for tumor profiling solutions while managing the full customer experience from order to report delivery.
Drive territory growth through new account acquisition and expansion of existing customer relationships for tumor profiling solutions. Build strong clinical relationships with oncologists and pathologists while ensuring a seamless customer experience from order to report delivery.
The Molecular Science Liaison communicates the value of Caris Molecular Intelligence to physicians and scientists through face-to-face discussions and presentations. They act as a conduit between the medical community and the company to enhance patient care and stay current on drug/biomarker associations.
Manage market access strategies and drive payer and health policy initiatives for the product portfolio. Lead the development of evidence generation plans and advocate for reimbursement coverage with commercial and government payers.
Drive the awareness and adoption of the MI Clarity AI-powered prognostic assay among oncologists and healthcare systems. Educate stakeholders on clinical value and integrate the assay into clinical workflows to optimize breast cancer patient care.
Establish and lead a team of Molecular Science Liaisons to communicate the value of Caris Molecular Intelligence to physicians and scientists. Manage national staffing, training plans, and act as a scientific conduit between the medical community and the company.
The Oncology Case Manager is responsible for maintaining and growing business with existing customers within an assigned territory. This includes managing the end-to-end customer experience from order initiation to the delivery of laboratory reports.
Drive territory growth through new account acquisition and the expansion of existing relationships with oncologists and pathologists. Manage the full customer experience from order initiation to report delivery for molecular profiling solutions.
Lead the architecture and optimization of scalable, secure cloud-native infrastructure using AWS and Kubernetes. Drive strategic technical roadmaps, implement GitOps pipelines, and ensure compliance with healthcare regulatory standards.
Lead a team of Account Executives to drive the regional and national adoption of the MI Clarity AI-powered prognostic assay. Develop and execute commercial strategies to expand market penetration within oncology, pathology, and integrated health systems.
Drive awareness and adoption of the MI Clarity AI-powered prognostic assay among oncologists and healthcare systems. Educate stakeholders on clinical utility and integrate the assay into clinical workflows to optimize breast cancer patient care.
Drive awareness and adoption of the MI Clarity AI-powered prognostic assay among oncologists and healthcare systems. Educate stakeholders on clinical utility and integrate the assay into clinical workflows to optimize patient care.
Drive awareness and adoption of the MI Clarity AI-powered prognostic assay among oncologists and healthcare systems. Educate stakeholders on clinical utility and integrate the assay into clinical workflows to optimize patient care.
Drive awareness and adoption of the MI Clarity AI-powered prognostic assay among oncologists and healthcare systems. Educate stakeholders on clinical utility and integrate the assay into clinical workflows to optimize breast cancer patient care.
Drive awareness and adoption of the MI Clarity AI-powered prognostic assay among oncologists and healthcare systems. Educate stakeholders on clinical utility and integrate the assay into clinical workflows to optimize breast cancer patient care.
Drive awareness and adoption of the MI Clarity AI-powered prognostic assay among oncology stakeholders. Educate healthcare providers on clinical utility and integrate the assay into clinical workflows to optimize patient care.
Drive awareness and adoption of the MI Clarity AI-powered prognostic assay among oncologists and healthcare systems. Educate stakeholders on clinical utility and integrate the assay into clinical workflows to optimize patient care.
Drive the awareness and adoption of the MI Clarity AI-powered prognostic assay among oncologists and healthcare systems. Educate stakeholders on clinical utility and integrate the assay into clinical workflows to optimize patient care.
Drive awareness and adoption of the MI Clarity AI-powered prognostic assay among oncologists and healthcare systems. Educate stakeholders on clinical utility and integrate the assay into clinical workflows to optimize breast cancer patient care.
Drive awareness and adoption of the MI Clarity AI-powered prognostic assay among oncologists and healthcare systems. Educate stakeholders on clinical utility and integrate the assay into clinical workflows to optimize breast cancer patient care.
Drive the awareness, adoption, and utilization of the MI Clarity AI-powered prognostic assay among oncology stakeholders. Educate healthcare providers on clinical utility and integrate the assay into clinical workflows to optimize patient care.
Drive awareness and adoption of the MI Clarity AI-powered prognostic assay among oncologists and healthcare systems. Educate stakeholders on clinical value and integrate the assay into clinical workflows to optimize breast cancer patient care.
Drive awareness and adoption of the MI Clarity AI-powered prognostic assay among oncologists and healthcare systems. Educate stakeholders on clinical value and integrate the assay into clinical workflows to optimize patient care.
Drive awareness and adoption of the MI Clarity AI-powered prognostic assay among oncologists and healthcare systems. Educate stakeholders on clinical utility and integrate the assay into clinical workflows to optimize patient care.
Drive awareness and adoption of the MI Clarity AI-powered prognostic assay among oncologists and healthcare systems. Educate stakeholders on clinical utility and integrate the assay into clinical workflows to optimize patient care.
Drive awareness and adoption of the MI Clarity AI-powered prognostic assay among oncologists and healthcare systems. Educate stakeholders on clinical value and integrate the assay into clinical workflows to optimize patient care.
Drive awareness and adoption of the MI Clarity AI-powered prognostic assay among oncologists and healthcare systems. Educate stakeholders on clinical utility and integrate the assay into clinical workflows to optimize patient care.
Drive awareness and adoption of the MI Clarity AI-powered prognostic assay among oncologists and healthcare systems. Educate stakeholders on clinical value and integrate the assay into clinical workflows to optimize patient care.
Drive awareness and adoption of the MI Clarity AI-powered prognostic assay among oncologists and healthcare systems. Educate stakeholders on clinical value and integrate the assay into clinical workflows to optimize patient care.
Drive awareness and adoption of the MI Clarity AI-powered prognostic assay among oncologists and healthcare systems. Educate stakeholders on clinical utility and integrate the assay into clinical workflows to optimize patient care.
Drive awareness and adoption of the MI Clarity AI-powered prognostic assay among oncologists and healthcare systems. Educate stakeholders on clinical value and integrate the assay into clinical workflows to optimize breast cancer patient care.
Manage executive-level relationships within complex health systems to drive the adoption of precision oncology solutions. Lead strategic initiatives, including program launches and workflow optimizations, while coordinating cross-functional teams to ensure sustainable growth.
The Oncology Case Manager manages end-to-end customer relationships to ensure high-quality experiences from order initiation to report delivery. The role focuses on maintaining and growing existing accounts through value-based relationships and strategic retention efforts.
Drive territory growth through new account acquisition and expansion of existing customer relationships within the oncology sector. Position Caris as the preferred provider of tumor profiling solutions by building strong clinical relationships with oncologists and pathologists.
Lead and manage strategic accounts across the New York Boroughs and New Jersey. Focus on driving growth and maintaining high-level client relationships.
Lead and develop a regional sales team of Account Managers and Specialists to drive revenue and adoption of Caris Detect. Manage strategic, executive-level relationships with academic medical centers and integrated delivery networks to embed diagnostics into clinical workflows.
Drive territory growth through new account acquisition and the expansion of existing customer relationships within the oncology sector. Position Caris as the preferred partner for tumor profiling solutions by building strong clinical relationships with oncologists and pathologists.
Drive territory growth through new account acquisition and expansion of existing relationships with oncologists and pathologists. Position Caris as the preferred provider for tumor profiling solutions while ensuring a seamless customer experience from order to report delivery.
The Oncology Case Manager is responsible for maintaining and growing business with existing customers within an assigned territory. This includes managing the end-to-end customer experience from order initiation to the delivery of laboratory reports.
The Oncology Account Executive is responsible for driving territory growth through strategic prospecting, new account acquisition, and the expansion of existing customer relationships. They provide clinical education and consultative support to oncologists and healthcare stakeholders to ensure the adoption of molecular profiling solutions.
The Embedded Caris Operations Manager is responsible for managing end-to-end operational workflows and case execution in support of client precision medicine programs. This role ensures reliable execution, workflow efficiency, and a high-quality provider and patient experience from order initiation through report delivery.
The Liquid Product Manager will manage the product roadmap from concept to commercial adoption, collaborating with local teams to ensure successful product delivery. They will also engage with clients to provide business solutions and analyze opportunities within the liquid oncology market.
